AUTL
Price
$1.28
Change
-$0.01 (-0.78%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
344.66M
111 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$14.34
Change
+$1.66 (+13.09%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.45B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AUTL vs NRIX

Header iconAUTL vs NRIX Comparison
Open Charts AUTL vs NRIXBanner chart's image
Autolus Therapeutics
Price$1.28
Change-$0.01 (-0.78%)
Volume$64.57K
Capitalization344.66M
Nurix Therapeutics
Price$14.34
Change+$1.66 (+13.09%)
Volume$27.67K
Capitalization1.45B
AUTL vs NRIX Comparison Chart in %
AUTL
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AUTL vs. NRIX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (AUTL: $1.29 vs. NRIX: $12.66)
Brand notoriety: AUTL and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 68% vs. NRIX: 49%
Market capitalization -- AUTL: $338M vs. NRIX: $1.45B
AUTL [@Biotechnology] is valued at $338M. NRIX’s [@Biotechnology] market capitalization is $1.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • AUTL’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRIX is a better buy in the long-term than AUTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 3 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • AUTL’s TA Score: 3 bullish, 6 bearish.
  • NRIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than AUTL.

Price Growth

AUTL (@Biotechnology) experienced а -13.67% price change this week, while NRIX (@Biotechnology) price change was -1.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

AUTL is expected to report earnings on Mar 10, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.45B) has a higher market cap than AUTL($345M). NRIX YTD gains are higher at: -32.803 vs. AUTL (-44.894). AUTL has higher annual earnings (EBITDA): -232.19M vs. NRIX (-248.7M). AUTL has more cash in the bank: 454M vs. NRIX (429M). NRIX has less debt than AUTL: NRIX (56.5M) vs AUTL (64.5M). NRIX has higher revenues than AUTL: NRIX (83.7M) vs AUTL (29.9M).
AUTLNRIXAUTL / NRIX
Capitalization345M1.45B24%
EBITDA-232.19M-248.7M93%
Gain YTD-44.894-32.803137%
P/E RatioN/AN/A-
Revenue29.9M83.7M36%
Total Cash454M429M106%
Total Debt64.5M56.5M114%
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLNRIX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDKOF6.76N/A
N/A
Idemitsu Kosan Co., Ltd.
SMDZF0.16N/A
N/A
Strategic Metals Ltd. New
SZGPF33.54N/A
N/A
Salzgitter AG
BACHY14.91-0.14
-0.96%
Bank of China, Ltd.
COOSF9.58-0.35
-3.52%
Carbios SA

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-3.36%
OCUL - AUTL
47%
Loosely correlated
-1.09%
IMTX - AUTL
46%
Loosely correlated
+8.99%
CRSP - AUTL
45%
Loosely correlated
-3.34%
NRIX - AUTL
45%
Loosely correlated
-1.02%
ALLO - AUTL
43%
Loosely correlated
+6.10%
More